Close menu

April 4th, 2022 | 11:20 CEST

Millions with innovations: BioNTech, Meta Materials, Varta

  • Technology
  • Biotechnology
Photo credits:

When the long-forgotten solar company SolarWorld went public in 1999, n-tv ran commercials that, from today's perspective, looked rather amateurish. At that time, too, only a few private investors were initially convinced by the Company. Years later, SolarWorld was a success story - investors from the very beginning had become rich. Even though the Company filed for insolvency in the meantime and burned a lot of money - SolarWorld investors of the first hour are mostly still wealthy. We explain where innovations can develop blockbuster potential.

time to read: 3 minutes | Author: Nico Popp
ISIN: BIONTECH SE SPON. ADRS 1 | US09075V1026 , Meta Materials Inc. | US59134N1046 , VARTA AG O.N. | DE000A0TGJ55

Table of contents:

    BioNTech: The market says "yes" to mRNA

    The example of BioNTech shows that the rise of industry giants does not necessarily have to take decades. Apart from the vaccine of Moderna, the mRNA specialist from Mainz has brought to market what is probably the best vaccine against COVID-19. It ensured a net profit of a whopping EUR 10 billion in just one year. In terms of profit, BioNTech has gone from a startup to a major corporation in just three years. Since the Company is well-positioned around mRNA technology and, unlike in the past, no longer has to go door-to-door to raise funds, the stock could also be promising.

    But between last summer and the beginning of March, the stock only went down. Most recently, BioNTech has been able to free itself a little and is preparing to leave the downward trend. In the medium term, the stock should overcome the EUR 200 mark to get back into more positive waters. However, the extent to which the share is still good for the multiplication that investors are hoping for remains to be seen. In the meantime, a lot seems to have been priced in around BioNTech and the mRNA technology.

    Meta Materials: More than a second Gamestop share

    Last summer, the market had also priced in a lot for Meta Materials: At its peak, the stock reached a whopping USD 21.76 on the US stock exchange Nasdaq. On a daily closing basis, there is still a high for the year of 7.49. Today, the stock is trading at USD 1.58. What has happened? Not much. Meta Materials wants to make so-called metamaterials presentable and enable industrial production at competitive prices. Metamaterials are artificial substances with properties that do not physically occur in nature. Concrete applications include transparent coatings that take on the function of antennas or coatings that refract light in such a way that objects become invisible because the light is deflected around them. What sounds like science fiction is reality - just not yet producible at such low cost. Meta Materials is confident, however, that it will soon be able to address this problem effectively.

    Until then, the Company is suffering the fate of many growth companies. The Company recently reported a loss and weak sales figures, and the market acknowledged the Company's news with share price losses. But the Company's field of activity is unique and offers the potential to become the "next big thing". The magazine "Spektrum der Wissenschaft" has already dedicated an entire topic page to metamaterials. Anyone interested in future technology can read up on it. Investors must decide for themselves whether the share has a future - the value does not appear expensive at present after the price losses.

    Varta: Rather conservative

    If you want to score with innovations, you should have a lot of know-how in your industry. And that is exactly the case for the battery manufacturer Varta. The Company scores with button cells for hearing aids and headphones and is also taking off with batteries for e-cars. Last week, Varta exceeded its guidance and analysts' expectations with its business figures for 2021. In 2022, sales are expected to increase from around EUR 900 million to EUR 950 million. From 2023, sales of rechargeable batteries for e-cars are to be the new revenue driver. However, the fantasy around e-cars is now out at Varta - the advance praise around the share was too great last year, and the battery perspective is too far away. It is also not clear whether Varta will truly be able to outdo the competition from around the world.

    While Varta is a laggard in the e-car battery space, Meta Materials is entering completely new territory with its approach. The perspective of the Nasdaq stock is thus similar to BioNTech at the beginning of the pandemic. Only the catalyst that will help Meta Materials achieve a breakthrough is currently still missing. However, many innovations are conceivable for Meta Materials in the areas of data glasses, smart displays, the energy transition, and telecommunications.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a "Transaction"). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
    In this respect, there is a concrete conflict of interest in the reporting on the companies.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
    For this reason, there is also a concrete conflict of interest.
    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by Armin Schulz on May 26th, 2022 | 11:22 CEST

    BioNTech, Meta Materials, Plug Power - Future stocks for tomorrow's profits

    • metamaterials
    • Technology
    • greenhydrogen

    Shares that focus on future trends harbor both risks and opportunities. If a breakthrough succeeds in a new area, high returns beckon. The business areas can be very different, but they have one thing in common: they will revolutionize people's lives in the future. Examples from the past include computers and cell phones, which ultimately permeated society. Today, we look at three companies that could significantly impact the future.


    Commented by Nico Popp on May 25th, 2022 | 10:44 CEST

    All eyes on Deutsche Bank and Commerzbank - but Aspermont has the greatest leverage

    • Investments
    • Technology
    • Mining

    The two best-known German banks are currently in demand on the market. Why? The interest rate turnaround means that the typical bread-and-butter business with loans is profitable again. Business picks up when banks have room to manoeuvre with interest rates in positive territory. Also, the increasingly weaker environment for corporate financing at the upper end of the risk scale ensures that banks take on a more critical role as traditional intermediaries. We take a closer look at Commerzbank and Deutsche Bank, but we also have an exciting second-tier stock on our list that could become an insider tip thanks to its unique selling propositions and growth potential.


    Commented by Stefan Feulner on May 23rd, 2022 | 13:01 CEST

    BioNTech, Monkeypox, Defence Therapeutics, Valneva - Is the next threat coming after Corona?

    • Biotechnology
    • Monkeypox

    The Corona pandemic is not over yet, but we should already prepare for future viruses. The next pandemic will come. When it will come is uncertain, and so is which pathogen will we have to deal with. Monkeypox is now spreading globally, and there are already the first cases in Germany. We find out what is known so far, where the dangers lie and what opportunities there are for the biotechnology sector from Dr Moutih Rafei, a renowned pharmacologist and head of research and development at the innovative company Defence Therapeutics Inc.